Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Disease-causing protein protects against nerve damage in Parkinson’s disease

04.11.2005


Researchers at UT Southwestern Medical Center have discovered that a protein associated with causing neurodegenerative conditions may, when appearing in normal amounts, actually protect against neurodegeneration.



The findings, appearing in today’s issue of the journal Cell, have surprised the researchers, because an excess of the same specific protein - alpha-synuclein - causes Parkinson’s disease.

"It’s the first time that anyone has shown that synuclein has any positive function at all in the body, and this is important because it’s been known to be involved in neurodegeneration," said Dr. Thomas Südhof, senior author of the study and director of the Center for Basic Neuroscience. Dr. Südhof also is an investigator in the Howard Hughes Medical Institute.


The key to their findings was determining the interaction between alpha-synuclein and another protein - cysteine-string-protein-alpha, or CSP-alpha. The researchers’ investigation involved several strains of mutant mice, which produced differing amounts of CSP-alpha or alpha-synuclein.

CSP-alpha is a "co-chaperone," meaning that it helps other proteins fold into their normal shapes, a vital process in the instantaneous reactions that occur at terminals of a nerve cell. When mutant mice lack only CSP-alpha, they appear normal for their first three weeks, then undergo rapid nerve degeneration and die at one to four months of age.

When mutant mice lack only alpha-synuclein, on the other hand, they continue to appear normal as they age, indicating that alpha-synuclein might not be essential in healthy nerve cells.

But mice that have been bred to produce an excess of human alpha-synuclein undergo a slowly progressing nerve degeneration resembling Parkinson’s.

The researchers bred mice lacking CSP with mice with excessive human synuclein in their brains, expecting to see a faster descent into the Parkinson’s-like symptoms in the offspring. Instead, they produced apparently healthy animals. In their terms, the alpha-synuclein "rescued" the mice from the harmful effects of lacking CSP-alpha.

The results were "exactly the opposite of what I expected," said Dr. Sreeganga Chandra, instructor in the Center for Basic Neuroscience and lead author of the study. "The rescued animals can live for one year or longer."

The researchers also bred mice that produced neither CSP-alpha nor alpha-synuclein and found they suffered neurodegeneration faster than mice just lacking CSP-alpha - another sign that alpha-synuclein protects against a lack of CSP-alpha.

In humans, clumps of alpha-synuclein, called Lewy bodies, are found in the brain cells of patients with Parkinson’s, Alzheimer’s and other degenerative diseases. The researchers speculate that the formation of Lewy bodies may take alpha-synuclein out of circulation in cells, thus removing its protective action.

Testing this hypothesis would involve looking for mutations in the genes for CSP-alpha or alpha-synuclein in patients with neurodegenerative diseases. "Trying to understand what’s going on in a dying brain is very difficult," said Dr. Südhof, who directs the Gill Center for Research on Brain Cell Communication and the C. Vincent Prothro Center for Research in Basic Neuroscience.

The researchers also found that alpha-synuclein doesn’t bind to or react with the same proteins that CSP-alpha does, so it doesn’t simply act as a substitute. However, both molecules bind to the membranes of synaptic vesicles - small spheres that contain the nerve cell’s neurotransmitters, chemicals that carry signals between brain cells - indicating that they both act at the vesicles’ surface.

"There’s a pathway, but we don’t really know all the players in this pathway," Dr. Chandra said.

Other researchers involved in the work were Gilbert Gallardo, student research assistant at the Center for Basic Neuroscience, and researchers from Germany and Spain.

The work was supported in part by the National Institutes of Health, the American Parkinson Disease Association and the Spanish Ministry of Education.

Aline McKenzie | EurekAlert!
Further information:
http://www.utsouthwestern.edu

More articles from Life Sciences:

nachricht Microscope measures muscle weakness
16.11.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

nachricht Good preparation is half the digestion
16.11.2018 | Max-Planck-Institut für Stoffwechselforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: UNH scientists help provide first-ever views of elusive energy explosion

Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.

Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

Purdue cancer identity technology makes it easier to find a tumor's 'address'

16.11.2018 | Health and Medicine

Good preparation is half the digestion

16.11.2018 | Life Sciences

Microscope measures muscle weakness

16.11.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>